India, May 19 -- Piramal Pharma Solutions (PPS), a leading global Contract Development and Manufacturing Organization (CDMO) and part of Mumbai-based Piramal Pharma, has entered a manufacturing and supply arrangement with Botanix SB Inc., a subsidiary of US-based Botanix Pharmaceuticals.

Under this arrangement, PPS will initiate development and validation services for Sofpironium Bromide, the active pharmaceutical ingredient (API) in Sofdra(R), at its Riverview, Michigan facility.

Following successful regulatory approval at Riverview, PPS and Botanix will consider validating the process at PPS's Aurora, Canada facility. This potential twin-site strategy would give Botanix the option to use PPS as a dual-source commercial API supplier, e...